Treatments

Featured Article

Viruses Most Common Cause of Meningitis, Encephalitis in the US

Viruses Most Common Cause of Meningitis, Encephalitis in the US

Researchers found that viruses were the most common cause of meningitis and encephalitis in the United States from 2011 to 2014.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News

Plant Bulbs Found to Carry Triazole-Resistant Aspergillus fumigatus

Plant Bulbs Found to Carry Triazole-Resistant Aspergillus fumigatus

Researchers find that the spread of triazole-resistant Aspergillus fumigatus is linked to plant bulbs.

Three Cases of Mumps Complications Investigated

Three Cases of Mumps Complications Investigated

Patients who received at least 2 doses of the recommended measles-mumps-rubella vaccine still suffered complications during an outbreak at the University of Iowa.

Quadrivalent Meningococcal Vaccine Linked to Bell's Palsy Risk

Quadrivalent Meningococcal Vaccine Linked to Bell's Palsy Risk

Bell's palsy is the only prespecified adverse event associated with the quadrivalent meningococcal conjugate vaccine.

CMV Titers Associated With Decrease Survival in Rheumatic Diseases

CMV Titers Associated With Decrease Survival in Rheumatic Diseases

Mortality in patients with rheumatic disease is associated with high cytomegalovirus titers.

Male Contraceptive Effective, But Adverse Events Problematic, Led to Early Study End

Male Contraceptive Effective, But Adverse Events Problematic, Led to Early Study End

Injections as effective as other contraceptives, but side effects prompted early halt of trial.

FDA: Boxed Warning Issued on Risk of HBV Using Certain HCV Drugs

FDA: Boxed Warning Issued on Risk of HBV Using Certain HCV Drugs

The FDA is mandating a Boxed Warning about the risk of HBV reactivation in certain HCV drugs.

FDA Grants N-Methanocarbathymidine Orphan Drug Designation

FDA Grants N-Methanocarbathymidine Orphan Drug Designation

N-Methanocarbathymidine,a novel thymidine analog antiviral being developed by N&N Pharmaceuticals Inc.,has now been granted Orphan Drug Designation by the FDA.

FDA Officials Approve New Balloon Device for Eustachian Tube Dysfunction

FDA Officials Approve New Balloon Device for Eustachian Tube Dysfunction

New balloon device approved to treat Eustachian tube dysfunction.

Vonoprazan-Based Triple Treatment May Be Effective Against H pylori

Vonoprazan-Based Triple Treatment May Be Effective Against H pylori

Vonoprazan-based triple therapy safe and effective compared with conventional PPI-based triple treatment.

Possible Bacterial Contamination Prompts Recall of Liquid Products

Possible Bacterial Contamination Prompts Recall of Liquid Products

If a product contains B. cepacia, its use could result in infections in patients with compromised immune systems.

Sign Up for Free e-newsletters